» Articles » PMID: 24860548

Diversity and Bias Through Receptor-Receptor Interactions in GPCR Heteroreceptor Complexes. Focus on Examples from Dopamine D2 Receptor Heteromerization

Overview
Specialty Endocrinology
Date 2014 May 27
PMID 24860548
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Allosteric receptor-receptor interactions in GPCR heteromers appeared to introduce an intermolecular allosteric mechanism contributing to the diversity and bias in the protomers. Examples of dopamine D2R heteromerization are given to show how such allosteric mechanisms significantly change the receptor protomer repertoire leading to diversity and biased recognition and signaling. In 1980s and 1990s, it was shown that neurotensin (NT) through selective antagonistic NTR-D2 like receptor interactions increased the diversity of DA signaling by reducing D2R-mediated dopamine signaling over D1R-mediated dopamine signaling. Furthermore, D2R protomer appeared to bias the specificity of the NTR orthosteric binding site toward neuromedin N vs. NT in the heteroreceptor complex. Complex CCK2R-D1R-D2R interactions in possible heteroreceptor complexes were also demonstrated further increasing receptor diversity. In D2R-5-HT2AR heteroreceptor complexes, the hallucinogenic 5-HT2AR agonists LSD and DOI were recently found to exert a biased agonist action on the orthosteric site of the 5-HT2AR protomer leading to the development of an active conformational state different from the one produced by 5-HT. Furthermore, as recently demonstrated allosteric A2A-D2R receptor-receptor interaction brought about not only a reduced affinity of the D2R agonist binding site but also a biased modulation of the D2R protomer signaling in A2A-D2R heteroreceptor complexes. A conformational state of the D2R was induced, which moved away from Gi/o signaling and instead favored β-arrestin2-mediated signaling. These examples on allosteric receptor-receptor interactions obtained over several decades serve to illustrate the significant increase in diversity and biased recognition and signaling that develop through such mechanisms.

Citing Articles

Chemokinergic and Dopaminergic Signalling Collaborates through the Heteromer Formed by CCR9 and Dopamine Receptor D5 Increasing the Migratory Speed of Effector CD4 T-Cells to Infiltrate the Colonic Mucosa.

Campos J, Osorio-Barrios F, Villanelo F, Gutierrez-Maldonado S, Vargas P, Perez-Acle T Int J Mol Sci. 2024; 25(18).

PMID: 39337509 PMC: 11432204. DOI: 10.3390/ijms251810022.


The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB Receptors.

Franco R, Morales P, Navarro G, Jagerovic N, Reyes-Resina I Front Pharmacol. 2022; 13:852631.

PMID: 35250601 PMC: 8889005. DOI: 10.3389/fphar.2022.852631.


Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence.

Villas-Boas G, Lavorato S, Paes M, Carvalho P, Rescia V, Cunha M Pharmaceuticals (Basel). 2021; 14(2).

PMID: 33673205 PMC: 7918669. DOI: 10.3390/ph14020148.


Conformational Basis of G Protein-Coupled Receptor Signaling Versatility.

Wingler L, Lefkowitz R Trends Cell Biol. 2020; 30(9):736-747.

PMID: 32622699 PMC: 7483927. DOI: 10.1016/j.tcb.2020.06.002.


Adenosine heteroreceptor complexes in the basal ganglia are implicated in Parkinson's disease and its treatment.

Borroto-Escuela D, Fuxe K J Neural Transm (Vienna). 2019; 126(4):455-471.

PMID: 30637481 PMC: 6456481. DOI: 10.1007/s00702-019-01969-2.


References
1.
Tarakanov A, Fuxe K . Triplet puzzle: homologies of receptor heteromers. J Mol Neurosci. 2009; 41(2):294-303. DOI: 10.1007/s12031-009-9313-5. View

2.
Fernandez-Duenas V, Gomez-Soler M, Jacobson K, Kumar S, Fuxe K, Borroto-Escuela D . Molecular determinants of A2AR-D2R allosterism: role of the intracellular loop 3 of the D2R. J Neurochem. 2012; 123(3):373-84. PMC: 3480334. DOI: 10.1111/j.1471-4159.2012.07956.x. View

3.
Kenakin T . '7TM receptor allostery: putting numbers to shapeshifting proteins. Trends Pharmacol Sci. 2009; 30(9):460-9. DOI: 10.1016/j.tips.2009.06.007. View

4.
McLean T, Parrish J, Braden M, Marona-Lewicka D, Gallardo-Godoy A, Nichols D . 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists. J Med Chem. 2006; 49(19):5794-803. DOI: 10.1021/jm060656o. View

5.
Luttrell L, Ferguson S, Daaka Y, Miller W, Maudsley S, Della Rocca G . Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science. 1999; 283(5402):655-61. DOI: 10.1126/science.283.5402.655. View